Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency

ABSTRACT Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host adaptation and associated changes in antibiotic susceptibility and virulence traits. Background: We report a case of a patient with partial recessive IFNγR1 deficiency who developed disseminated BCG infection after neonatal vaccination (BCG-vaccine). Distinct M. bovis BCG-vaccine derived clinical strains were recovered from the patient’s lungs and brain. Methods: BCG strains were phenotypically (growth, antibiotic susceptibility, lipid) and genetically (whole genome sequencing) characterized. Mycobacteria cell infection models were used to assess apoptosis, necrosis, cytokine release, autophagy, and JAK-STAT signaling. Results: Clinical isolates BCG-brain and BCG-lung showed distinct Rv0667 rpoB mutations conferring high- and low-level rifampin resistance; the latter displayed clofazimine resistance through Rv0678 gene (MarR-like transcriptional regulator) mutations. BCG-brain and BCG-lung showed mutations in fadA2, fadE5, and mymA operon genes, respectively. Lipid profiles revealed reduced levels of PDIM in BCG-brain and BCG-lung and increased TAGs and Mycolic acid components in BCG-lung, compared to parent BCG-vaccine. In vitro infected cells showed that the BCG-lung induced a higher cytokine release, necrosis, and cell-associated bacterial load effect when compared to BCG-brain; conversely, both strains inhibited apoptosis and altered JAK-STAT signaling. Conclusions: During a chronic-disseminated BCG infection, BCG strains can evolve independently at different sites likely due to particular microenvironment features leading to differential antibiotic resistance, virulence traits resulting in dissimilar responses in different host tissues.

[1]  M. Behr,et al.  Bacillus Calmette–Guérin strains with defined resistance mutations: a new tool for tuberculosis laboratory quality control , 2020 .

[2]  J. Casanova,et al.  Mendelian susceptibility to mycobacterial disease: 2014–2018 update , 2018, Immunology and cell biology.

[3]  J. Casanova,et al.  Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23 , 2018, Science Immunology.

[4]  A. Tyagi,et al.  Necrosis Driven Triglyceride Synthesis Primes Macrophages for Inflammation During Mycobacterium tuberculosis Infection , 2018, Front. Immunol..

[5]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[6]  R. Brosch,et al.  Evolution of virulence in the Mycobacterium tuberculosis complex. , 2018, Current opinion in microbiology.

[7]  R. Brosch,et al.  ESX‐1 and phthiocerol dimycocerosates of Mycobacterium tuberculosis act in concert to cause phagosomal rupture and host cell apoptosis , 2017, Cellular microbiology.

[8]  Jonathan Crabtree,et al.  CloVR-Comparative: automated, cloud-enabled comparative microbial genome sequence analysis pipeline , 2017, BMC Genomics.

[9]  Bin Wang,et al.  Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis , 2017, Antimicrobial Agents and Chemotherapy.

[10]  R. Mariuzza,et al.  The Cell Wall Lipid PDIM Contributes to Phagosomal Escape and Host Cell Exit of Mycobacterium tuberculosis , 2017, mBio.

[11]  Venkatram R. Mereddy,et al.  Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents. , 2016, Tetrahedron.

[12]  K. Lewis,et al.  High Persister Mutants in Mycobacterium tuberculosis , 2016, PloS one.

[13]  N. Petronella,et al.  Choice of reference-guided sequence assembler and SNP caller for analysis of Listeria monocytogenes short-read sequence data greatly influences rates of error , 2015, BMC Research Notes.

[14]  Tareq B. Malas,et al.  Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations , 2015, Scientific Reports.

[15]  W. Shi,et al.  Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis. , 2015, The Journal of antimicrobial chemotherapy.

[16]  J. Kere,et al.  Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. , 2015, Blood.

[17]  R. Kay,et al.  Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion , 2014, EMBO molecular medicine.

[18]  S. Kaufmann,et al.  Perspectives on host adaptation in response to Mycobacterium tuberculosis: modulation of inflammation. , 2014, Seminars in immunology.

[19]  H. Mollenkopf,et al.  AhR sensing of bacterial pigments regulates antibacterial defence , 2014, Nature.

[20]  B. Goldstein.  Resistance to rifampicin: a review , 2014, The Journal of Antibiotics.

[21]  R. Geffers,et al.  Experimental selection of long-term intracellular mycobacteria , 2014, Cellular microbiology.

[22]  J. Franco,et al.  BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies. , 2014, The Journal of allergy and clinical immunology.

[23]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[24]  S. Cole,et al.  Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis , 2014, Antimicrobial Agents and Chemotherapy.

[25]  C. Fraser,et al.  High-level Relatedness among Mycobacterium abscessus subsp. massiliense Strains from Widely Separated Outbreaks , 2014, Emerging infectious diseases.

[26]  Carlos Martín,et al.  ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question , 2013, Front. Cell. Infect. Microbiol..

[27]  Michael Roberts,et al.  The MaSuRCA genome assembler , 2013, Bioinform..

[28]  Joel S. Freundlich,et al.  Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis , 2013, Nature chemical biology.

[29]  E. Sampaio,et al.  Interferon Alpha Treatment of Patients with Impaired Interferon Gamma Signaling , 2013, Journal of Clinical Immunology.

[30]  K. Zoon,et al.  Type I interferons induce autophagy in certain human cancer cell lines , 2013, Autophagy.

[31]  A. Cataldi,et al.  Virulence factors of the Mycobacterium tuberculosis complex , 2013, Virulence.

[32]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[33]  F. Chan,et al.  Detection of necrosis by release of lactate dehydrogenase activity. , 2013, Methods in molecular biology.

[34]  E. Coccia,et al.  ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells , 2012, Autophagy.

[35]  S. Majumdar,et al.  IL-6 inhibits IFN-γ induced autophagy in Mycobacterium tuberculosis H37Rv infected macrophages. , 2012, The international journal of biochemistry & cell biology.

[36]  D. Rasko,et al.  Phylomark, a Tool To Identify Conserved Phylogenetic Markers from Whole-Genome Alignments , 2012, Applied and Environmental Microbiology.

[37]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[38]  Jonathan Crabtree,et al.  Using Sybil for interactive comparative genomics of microbes on the web , 2011, Bioinform..

[39]  J. Keane,et al.  IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. , 2011, American journal of respiratory cell and molecular biology.

[40]  M. Makino,et al.  Apoptosis-Inducing Activity of Clofazimine in Macrophages , 2011, Antimicrobial Agents and Chemotherapy.

[41]  H. Maamar,et al.  Mycobacterium tuberculosis Uses Host Triacylglycerol to Accumulate Lipid Droplets and Acquires a Dormancy-Like Phenotype in Lipid-Loaded Macrophages , 2011, PLoS pathogens.

[42]  K. Nadeau,et al.  STAT5b deficiency: lessons from STAT5b gene mutations. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[43]  J. Casanova,et al.  Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. , 2011, Human molecular genetics.

[44]  N. Maulén.  [Virulence factors of Mycobacterium tuberculosis]. , 2011, Revista medica de Chile.

[45]  S. Behar,et al.  Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? , 2010, Nature Reviews Microbiology.

[46]  S. Behar,et al.  Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis , 2010, Nature Immunology.

[47]  M. Daffé,et al.  Delineation of the roles of FadD22, FadD26 and FadD29 in the biosynthesis of phthiocerol dimycocerosates and related compounds in Mycobacterium tuberculosis , 2010 .

[48]  M. Daffé,et al.  Delineation of the roles of FadD22, FadD26 and FadD29 in the biosynthesis of phthiocerol dimycocerosates and related compounds in Mycobacterium tuberculosis. , 2010, The FEBS journal.

[49]  H. Dockrell,et al.  Complex cytokine profiles induced by BCG vaccination in UK infants , 2010, Vaccine.

[50]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[51]  I. Bastian,et al.  Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results , 2009, Journal of Clinical Microbiology.

[52]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[53]  R. Reljic,et al.  TNF-α in Tuberculosis: A Cytokine with a Split Personality , 2009 .

[54]  D. Minnikin,et al.  A Simple Mycobacterial Monomycolated Glycerol Lipid Has Potent Immunostimulatory Activity1 , 2009, The Journal of Immunology.

[55]  E. Riley,et al.  IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.

[56]  A. Pandiella,et al.  Mechanism of apoptosis induced by IFN-alpha in human myeloma cells: role of Jak1 and Bim and potentiation by rapamycin. , 2007, Cellular signalling.

[57]  B. Plikaytis,et al.  The acid-induced operon Rv3083-Rv3089 is required for growth of Mycobacterium tuberculosis in macrophages. , 2007, Tuberculosis.

[58]  G. Bjune,et al.  The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low‐level protection by bacille Calmette–Guérin (BCG) vaccines: is there a link? , 2006, Clinical and experimental immunology.

[59]  Serge Haan,et al.  Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation. , 2005, Cellular signalling.

[60]  Amit Singh,et al.  Requirement of the mymA Operon for Appropriate Cell Wall Ultrastructure and Persistence of Mycobacterium tuberculosis in the Spleens of Guinea Pigs , 2005, Journal of bacteriology.

[61]  M. Glickman,et al.  Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule , 2005, The Journal of experimental medicine.

[62]  S. Holland,et al.  Defects in the interferon‐γ and interleukin‐12 pathways , 2005, Immunological reviews.

[63]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[64]  Brigitte Gicquel,et al.  Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection , 2004, Cellular microbiology.

[65]  A. Ullrich,et al.  Interplay between mycobacteria and host signalling pathways , 2004, Nature Reviews Microbiology.

[66]  Christopher M. Sassetti,et al.  Genetic requirements for mycobacterial survival during infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  N. Reiner,et al.  Survival of Mycobacterium tuberculosis in Host Macrophages Involves Resistance to Apoptosis Dependent upon Induction of Antiapoptotic Bcl-2 Family Member Mcl-11 , 2003, The Journal of Immunology.

[68]  S. Gillespie,et al.  Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective , 2002, Antimicrobial Agents and Chemotherapy.

[69]  D. Minnikin,et al.  Separation and characterization of individual mycolic acids in representative mycobacteria. , 2001, Microbiology.

[70]  Gerhard Walzl,et al.  Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection , 2001, Nature Medicine.

[71]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[72]  T. Riss,et al.  Poly (ADP-ribose) polymerase cleavage monitored in situ in apoptotic cells. , 2001, BioTechniques.

[73]  C. E. Barry,et al.  Analysis of the Lipids of Mycobacterium tuberculosis. , 2001, Methods in molecular medicine.

[74]  M. Glickman,et al.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. , 2000, Molecular cell.

[75]  Eugene W. Myers,et al.  A whole-genome assembly of Drosophila. , 2000, Science.

[76]  R. Young,et al.  Increased Antimycobacterial Immunity in Interleukin-10-Deficient Mice , 1999, Infection and Immunity.

[77]  S. Fowler,et al.  Nile red: a selective fluorescent stain for intracellular lipid droplets , 1985, The Journal of cell biology.